Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$214,582
+$4,208 QoQ
Shares Held
428
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,248
of 2,606 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NCM Capital Management, LLC holds $420,300 across 2 Diagnostics & Research names. TMO ranks #1 (51.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
428 | $214,582 | |
| 2 | DHR |
Danaher Corp /De/
|
1,080 | $205,718 |
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,582 | 428 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $210,374 | 428 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $248,004 | 428 | Shares | Sole | 2026-03-02 | |
| 2025-09-30 | $207,588 | 428 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $246,312 | 495 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $257,513 | 495 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $306,192 | 495 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $273,735 | 495 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $287,698 | 495 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $263,802 | 497 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $221,702 | 438 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||